Pre-Exposure Prophylaxis study (treated before exposed to the virus)
et al., medRxix, doi:10.1101/2020.06.09.20116806 (Preprint)
Pre exposure Hydroxych loroquine use is associated with reduced COVID19 risk in healthcare workers
Q reduced cases from 38% to 7%. 106 people. No serious adverse effects.
COVID-19 case, ↓80.7%, p=0.001
Please send us corrections, updates, or comments.